Accordingly, dual PI3K/BET inhibition blocked the PI3K/Akt pathway by eliminating the feedback loop reactivating the PI3K pathway in the presence of the PI3K single agent, attenuated cell growth in multiple in vitro tumor models and displayed in vivo antitumor action [240]. Here, AKT1 is linked to neoplasm.